Metabolic surgery-principles and current concepts (Q37922651)

25 August 2017

1 reference

title

Metabolic surgery-principles and current concepts (English)

1 reference

25 August 2017

M Gass

1

1 reference

25 August 2017

C Beglinger

series ordinal

2

1 reference

25 August 2017

R Peterli

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

26 August 2011

1 reference

Langenbeck's Archives of Surgery

25 August 2017

1 reference

25 August 2017

396

1 reference

25 August 2017

7

1 reference

25 August 2017

949-972

1 reference

https://scigraph.springernature.com/pub.10.1007/s00423-011-0834-3

25 August 2017

0 references

cites work

Increases in morbid obesity in the USA: 2000-2005

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The role of peptide YY in appetite regulation and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Excess deaths associated with underweight, overweight, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Cause-specific excess deaths associated with underweight, overweight, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Evolution of operative procedures for the management of morbid obesity 1950-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Jejunoileal bypass for morbid obesity. A critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Preoperative preparation, operative technique, and postoperative care of patients undergoing jejunoileal bypass for massive exogenous obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Alterations of central dopamine receptors before and after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Biological actions and therapeutic potential of the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gastric surgery for relief of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Vertical ring gastroplasty for morbid obesity. Five year experience with 1,463 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

A Review of Seven Years' Experience with Silicone Gastric Banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Prospective study of a two-stage operative concept in the treatment of morbid obesity: primary lap-band followed if needed by sleeve gastrectomy with duodenal switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Long-term results of a prospective study on laparoscopic adjustable gastric banding for morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic adjustable gastric banding in the treatment of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic Gastric Bypass, Roux-en-Y: Technique and Results in 75 Patients With 3-30 Months Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Biliopancreatic diversion with a duodenal switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bilio-pancreatic bypass for obesity: II. Initial experience in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Ghrelin: new molecular pathways modulating appetite and adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Cell biology of the ghrelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gastrointestinal regulation of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Changes in ghrelin levels following bariatric surgery: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Ghrelin: a gut-brain hormone: effect of gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Peptide YY levels are elevated after gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Short-term effects of gastric bypass surgery on circulating ghrelin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Neuroendocrine regulation of eating behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Satiety effects of a physiological dose of cholecystokinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Luminal influences to orchestrate gastroenterological hormone secretion: the fat, long-chain Fatty Acid, cholecystokinin, glucagon-like Peptide 1 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

K-cells and glucose-dependent insulinotropic polypeptide in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The entero-insular axis in type 2 diabetes--incretins as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

GIP and bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Time-resolved MRI after ingestion of liquids reveals motility changes after laparoscopic sleeve gastrectomy--preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Hormone changes affecting energy homeostasis after metabolic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The area postrema lesions alter the inhibitory effects of peripherally infused pancreatic polypeptide on pancreatic secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The satiety hormone peptide YY as a regulator of appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of total colectomy and PYY infusion on food intake and body weight in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The gut hormone peptide YY regulates appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Peptide YY: a potential therapy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of peptide YY3-36 on food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

From observation to experimentation: leptin action in the mediobasal hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Twenty-Four-Hour Leptin Levels Respond to Cumulative Short-Term Energy Imbalance and Predict Subsequent Intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The stomach is a source of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The metabolic consequences of sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Perceived psychological stress and serum leptin concentrations in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gut and adipocyte peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Appetite regulation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Hypothalamic clamp on insulin release by leptin-transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effectiveness of therapeutic interventions in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Leptin in morbidly obese patients: no role for treatment of morbid obesity but important in the postoperative immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Do leptin and insulin signal adiposity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Adiponectin: a link between excess adiposity and associated comorbidities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of weight loss on coronary circulation and adiponectin levels in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of marked weight loss on adiponectin gene expression and plasma concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Bile acids and the membrane bile acid receptor TGR5--connecting nutrition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Insulin resistance, adipose depots and gut: interactions and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Rapid upregulation of sodium-glucose transporter SGLT1 in response to intestinal sweet taste stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Slow-progression, autoimmune, type 1 diabetes in adults: a cause of failure of resolution of diabetes after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Comment on: prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0834-3

Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

21 January 2018

1 reference

12 December 2020

Biliopancreatic Diversion with a New Type of Gastrectomy

1 reference

12 December 2020

Different effects of vertical banded gastroplasty and Roux-en-Y gastric bypass on meal inhibition of ghrelin secretion in morbidly obese patients

1 reference

12 December 2020

Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats

1 reference

12 December 2020

Laparoscopic biliopancreatic diversion for the treatment of morbid obesity: initial experience

1 reference

12 December 2020

Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers

1 reference

12 December 2020

The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)

1 reference

12 December 2020

Impact of gastric banding on plasma adiponectin levels

1 reference

12 December 2020

Surgical treatment of obesity

1 reference

12 December 2020

Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes

1 reference

12 December 2020

Laparoscopic adjustable gastric banding: complications and side effects responsible for the poor long-term outcome

1 reference

12 December 2020

Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery

1 reference

12 December 2020

The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes

1 reference

12 December 2020

Gastric Banding for Morbid Obesity: Initial Experience with a New Adjustable Band

1 reference

12 December 2020

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

1 reference

12 December 2020

Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles

1 reference

12 December 2020

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up

1 reference

12 December 2020

From bariatric to metabolic surgery in non-obese subjects: time for some caution

1 reference

12 December 2020

The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up

1 reference

12 December 2020

Vertical banded gastroplasty for obesity

1 reference

12 December 2020

Basolateral D-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2

1 reference

12 December 2020

Plasma cholecystokinin levels after vertical banded gastroplasty: effects of an acidified meal

1 reference

12 December 2020

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

1 reference

12 December 2020

The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study.

1 reference

12 December 2020

Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content

1 reference

12 December 2020

Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels

1 reference

12 December 2020

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

1 reference

12 December 2020

Effects of Ingestion of Triglyceride or Galactose on Secretion of Gastric Inhibitory Polypeptide and on Responses to Intravenous Glucose in Normal and Diabetic Subjects

1 reference

12 December 2020

Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients.

1 reference

12 December 2020

Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

Fundus functionality and ghrelin concentrations after bariatric surgery

1 reference

12 December 2020

Obesity as a medical problem

1 reference

12 December 2020

Sleeve gastrectomy: a restrictive procedure?

1 reference

12 December 2020

Control of body weight by lower gut signals

1 reference

12 December 2020

Gastroplasty in Morbid Obesity

1 reference

12 December 2020

Surgery for diabetes at lower BMI: some caution

1 reference

12 December 2020

A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity

1 reference

12 December 2020

Sleeve gastrectomy-a "food limiting" operation

1 reference

12 December 2020

Gastric bypass in obesity

1 reference

12 December 2020

Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation

1 reference

12 December 2020

Obese, a new mutation in the house mouse

1 reference

12 December 2020

IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

1 reference

12 December 2020

Twenty-four-hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake

1 reference

12 December 2020

Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality?

1 reference

12 December 2020

Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat

1 reference

12 December 2020

A bypass operation for obese hyperlipidemic patients

1 reference

12 December 2020

The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

The effects of gastric surgery on systemic ghrelin levels in the morbidly obese

1 reference

12 December 2020

Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")--pilot study of a new operation

1 reference

12 December 2020

Biliopancreatic diversion with duodenal switch

1 reference

12 December 2020

Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database

1 reference

12 December 2020

An experimental evaluation of the nutritional importance of proximal and distal small intestine

1 reference

12 December 2020

The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans

1 reference

12 December 2020

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

1 reference

12 December 2020

Gastric bypass increases energy expenditure in rats

1 reference

12 December 2020

Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

1 reference

12 December 2020

10.1007/S00423-011-0834-3

Identifiers

DOI

1 reference

25 August 2017

1 reference